Pain Elimination and Anxiety Control Through Experiential Virtual Reality
NCT ID: NCT06504602
Last Updated: 2024-07-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
96 participants
INTERVENTIONAL
2024-09-01
2025-03-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Will active virtual reality reduce pain score on Faces Pain Scale - revised and measure of heart rate during intravenous placement for children ages 8 years old to 21 years old more than passive virtual reality and standard of care?
* Will active virtual reality reduce anxiety score on Visual Analog Scale - revised and measure of heart rate during intravenous placement for children ages 8 years old to 21 years old more than passive virtual reality and standard of care?
If there is a comparison group: Researchers will compare active group to passive group and standard of care.
Participants will randomized into active virtual reality, passive virtual reality or standard of care arms.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
VR to Reduce Pain/Anxiety During Painful Procedures
NCT04268901
Pain Procedures and Anxiolysis Via Distraction With Virtual Reality
NCT04437173
VR to Reduce Pain/Anxiety During IV Starts
NCT04942561
Virtual Reality vs Passive Distraction for Pain Management
NCT03680625
The Effect of VR on Pain, Anxiety And Fear During Venipuncture in Children
NCT06527092
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active Virtual Reality
Within the active virtual reality group virtual environment, participants will play the game Bearblast using Oculus Go Headset for patients 8-21 years old. In BearBlast, participants travel on a pre-set path through an interactive environment.
Active Virtual Reality
Active virtual reality group will play a game through a virtual environment.
Passive Virtual Reality
Within the passive virtual reality group virtual environment and age appropriate movie.
Passive Virtual Reality
Passive virtual reality group will watch a movie through a virtual environment.
Standard of Care
Participants will receive standard of care distraction methods.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Active Virtual Reality
Active virtual reality group will play a game through a virtual environment.
Passive Virtual Reality
Passive virtual reality group will watch a movie through a virtual environment.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ability to understand study procedures and to comply with them for the entire length of the study.
* Participants and caregiver speaking English or Spanish.
Exclusion Criteria
* Participants receiving narcotics, opioids, or anxiolytics 8 hours prior (Tylenol and ibuprofen do not count).
* Participants with pain so significant that consent/assent is not possible (decision based on treating clinician evaluation).
* Critically ill Participants (ESI 1).
8 Years
21 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Children's Hospital Los Angeles
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Matan Paret
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Matan Paret, MD
Role: PRINCIPAL_INVESTIGATOR
Children's Hospital Los Angeles
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHLA-24-00171
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.